Citation Impact
Citing Papers
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
2008
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Air pollution and daily admissions for chronic obstructive pulmonary disease in 6 European cities: results from the APHEA project
1997
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years
1999
Prognosis and Management after a First Myocardial Infarction
1990
Epidemiology of Parkinson's disease
2006 Standout
A Metaregression Analysis of the Dose-Response Effect of Aspirin on Stroke
1999
Parkinson's disease
2009 Standout
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
1996 Standout
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique
1991
Antithrombotic Therapy for VTE Disease
2012 Standout
Platelet Activation and Atherothrombosis
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Diabetes and Atherosclerosis
2002 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
The pathophysiology of cigarette smoking and cardiovascular disease
2004 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Warfarin, Aspirin, or Both after Myocardial Infarction
2002
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Prophylactic aspirin and risk of peptic ulcer bleeding
1995
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Platelet Spontaneous Aggregation in Platelet-Rich Plasma Is Increased in Habitual Smokers
1999
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Hemorrhagic Complications of Anticoagulant Treatment
1998
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Low-Dose Aspirin Therapy for Chronic Stable Angina
1991
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
1989
Levodopa-Induced Neurotoxicity
1997
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Attempts to obtain neuroprotection in Parkinson's disease
1997
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Potential therapeutic applications of aspirin and other cyclo‐oxygenase inhibitors.
1980
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
Aspirin after myocardial infarction
1989
Review papers : The statistical basis of meta-analysis
1993
Influence of Diabetes Mellitus on Early and Late Outcome After Percutaneous Transluminal Coronary Angioplasty
1995
Quantitative Synthesis in Systematic Reviews
1997 Standout
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
1993
Aspirin and Other Platelet-Active Drugs
1992
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1989
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
1987
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
1994
Hemorrhagic Complications of Anticoagulant Treatment
1992
Blood pressure, stroke, and coronary heart disease
1990 Standout
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1986
Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
1983
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
2001 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement
1980
Hemorrhagic Complications of Anticoagulant Treatment
1995
Should treatment of Parkinson's disease be started with a dopamine agonist?
1998
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Secondary prevention after myocardial infarction: A review of long-term trials
1982
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
The randomized clinical trial: bias in analysis.
1981
Meta-analysis in clinical trials
1986 Standout
Vessel injury, platelet adherence, and platelet survival.
1983
Works of K. Überla being referenced
Boundaries of Perception and Knowledge for Risk Assessment in Epidemiology
1990
Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued
1992
Secondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon
1980
Meta‐analyses on passive smoking and lung cancer effects of study selection and misclassification of exposure
1988
Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo
1979
German-Austrian Multicenter two Years Prospective study on the Prevention of Secondary Myocardial Infarction by ASA in Comparison of Phenprocoumon and Placebo
1977
Spontaneous platelet aggregation and coagulation parameters as risk factors for arterial occlusions in diabetics. Results of the PARD-study.
1987
PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
1985